Johns Disease (Lymphocytic Choriomeningitis)
Overview
Lymphocytic choriomeningitis (LCM), sometimes called “Johns disease,” is an acute viral infection of the central nervous system (CNS) caused by the Lymphocytic choriomeningitis virus (LCMV). The virus belongs to the arenavirus family and is primarily carried by the common house mouse (Mus musculus). Human infection occurs when people inhale aerosolized rodent excreta, ingest contaminated food or water, or receive a transplant or blood transfusion from an infected donor.
Although LCM is relatively rare, it can affect anyone who lives or works in close proximity to rodents. In the United States, seroprevalence studies suggest that 3–5 % of the general population has antibodies to LCMV, indicating prior exposure, but clinically apparent disease occurs in < 0.5 % of those infected.[1] CDC, 2022 Worldwide, sporadic outbreaks have been reported in Europe, Asia, and Africa, often linked to poor rodent control in urban settings or to organ‑transplant transmission.
Symptoms
The clinical picture of LCM can be divided into three phases: an initial prodrome, a neurologic phase, and (rarely) a chronic or post‑infectious phase. Not every patient experiences all symptoms.
Typical symptom timeline
- Incubation period: 1–3 weeks after exposure.
- Prodromal phase (3–7 days): low‑grade fever, chills, headache, malaise, muscle aches, and sore throat.
- Neurologic phase (4–10 days): meningitis‑like signs, encephalitis, or meningoencephalitis.
Full symptom list
- Fever ≥ 38 °C (100.4 °F) – often the first sign.
- Severe headache – typically frontal or retro‑orbital.
- Neck stiffness (nuchal rigidity) – hallmark of meningitis.
- Photophobia – sensitivity to light.
- Altered mental status – confusion, lethargy, or agitation.
- Seizures – reported in 10–15 % of neurologic cases.
- Focal neurologic deficits – weakness, speech difficulty, or visual changes.
- Vomiting or nausea – often with headache.
- Myalgia and arthralgia – muscle and joint aches.
- Rash – maculopapular rash in ~20 % of patients, more common in children.
- Hearing loss or vestibular dysfunction – rare but reported.
- Fatigue lasting weeks to months – especially after neurologic involvement.
In immunocompromised individuals (e.g., transplant recipients, HIV patients), the disease may present atypically with prolonged fever, disseminated infection, or organ‑specific involvement (e.g., hepatitis, pneumonitis).
Causes and Risk Factors
Etiology
LCMV is an RNA virus transmitted primarily through contact with infected rodents:
- Inhalation: aerosolized urine, feces, or saliva.
- Ingestion: contaminated food or water.
- Direct contact: bites or scratches.
- Vertical transmission: from a pregnant woman to the fetus.
- Transplant‑related transmission: infected donor organs or blood products.
Who is at higher risk?
- People living in rodent‑infested homes, barns, or warehouses.
- Workers in pest control, laboratory animal facilities, or wildlife rehabilitation.
- Pregnant women – fetal infection can cause severe congenital disease.
- Immunocompromised patients (solid‑organ or stem‑cell transplant recipients, chemotherapy patients, HIV/AIDS).
- Infants and young children – more likely to have close contact with household mice.
Key statistics
- In the United States, CDC estimates ~2,000–3,000 symptomatic cases per year.[2]
- Mortality among symptomatic adults is 1–5 %; it rises to 15–30 % in immunocompromised patients.[3] Mayo Clinic, 2023
- Congenital LCMV infection occurs in <1 per 10,000 live births, but may be under‑diagnosed.[4] WHO, 2021
Diagnosis
Clinical suspicion
Because early symptoms mimic other viral infections, clinicians should consider LCMV when there is:
- Recent rodent exposure or a known outbreak.
- A combination of meningitis/encephalitis signs with a prodrome of fever and myalgia.
- Pregnancy or immunosuppression with unexplained CNS inflammation.
Laboratory tests
- Serology: detection of LCMV‑specific IgM (acute infection) and IgG (past exposure). Enzyme‑linked immunosorbent assay (ELISA) is the most common method.
- Polymerase chain reaction (PCR): viral RNA can be identified in serum, cerebrospinal fluid (CSF), or tissue samples. PCR offers the highest sensitivity during the first 2 weeks of illness.
- Cerebrospinal fluid (CSF) analysis:
- Pleocytosis – typically lymphocytic (>70 % of cells).
- Elevated protein (50–100 mg/dL).
- Normal or mildly low glucose.
- Neuroimaging: MRI may show hyperintense lesions in the basal ganglia, thalamus, or brainstem, especially in encephalitic cases.
- Histopathology (rare): brain biopsy showing perivascular lymphocytic infiltrates; usually reserved for diagnostic dilemmas.
Differential diagnosis
Other conditions that mimic LCMV include:
- Enteroviral meningitis
- Herpes simplex virus encephalitis
- West Nile virus infection
- Autoimmune encephalitis
- Neurosyphilis (especially in pregnant women)
Treatment Options
Supportive care (mainstay)
- Hydration and electrolyte management.
- Antipyretics (acetaminophen or ibuprofen) for fever and headache.
- Analgesics for muscle aches.
- Monitoring for seizures – prompt administration of benzodiazepines if needed.
- Intensive care support for respiratory failure or increased intracranial pressure.
Antiviral therapy
There is no FDA‑approved antiviral specifically for LCMV, but limited case series suggest possible benefit from:
- Ribavirin: administered intravenously (10–15 mg/kg every 6 h) for severe encephalitis; outcomes are mixed, and therapy is usually reserved for immunocompromised patients.[5] JAMA Neurology, 2020
- Favipiravir: experimental oral agent with in‑vitro activity against arenaviruses; clinical data are still emerging.
Adjunctive therapies
- Corticosteroids – occasionally used to reduce cerebral edema, but evidence is anecdotal.
- Immunoglobulin (IVIG) – may help in transplant‑related LCMV infection.
Lifestyle and home measures
- Rest and gradual return to activity after acute illness.
- Avoid alcohol and sedating medications while recovering.
- Maintain adequate nutrition and hydration.
Living with Johns disease (Lymphocytic choriomeningitis)
Recovery timeline
Most otherwise healthy adults recover within 2–4 weeks. Persistent fatigue, mild cognitive fog, or headaches can linger for months (“post‑viral syndrome”). Rehabilitation may involve:
- Physical therapy for balance or weakness.
- Neurocognitive exercises if memory or concentration are affected.
- Psychological support – anxiety about recurrence is common.
Tips for daily management
- Track symptoms: keep a daily log of headache severity, temperature, and new neurologic signs.
- Medication adherence: take any prescribed antivirals or seizure prophylaxis exactly as directed.
- Sleep hygiene: aim for 7–9 hours of uninterrupted sleep; use a dark, quiet bedroom.
- Hydration: at least 2 L of water per day unless contraindicated.
- Limit stimulants: caffeine and nicotine can aggravate headaches.
- Stay up‑to‑date on vaccinations: influenza and COVID‑19 vaccines reduce the risk of co‑infection that can complicate recovery.
- Work/School accommodations: request flexible hours or remote work during the first few weeks after discharge.
When to contact your doctor
- Fever persisting >48 hours after the initial episode.
- New or worsening neurologic symptoms (e.g., weakness, vision changes).
- Severe, unrelenting headache that does not improve with OTC analgesics.
Prevention
Rodent control
- Seal cracks, gaps, and openings in walls, foundations, and roofs.
- Store food in rodent‑proof containers; clean up crumbs promptly.
- Eliminate standing water and reduce clutter where mice can nest.
- Use snap traps or electronic traps; avoid poison that can create contaminated carcasses.
- Professional pest‑control services for infestations larger than a few mice.
Personal protection
- Wear disposable gloves and a N95 mask when cleaning rodent droppings or nests.
- Disinfect surfaces with a 1:10 bleach solution (0.5 % sodium hypochlorite) and let it sit for at least 10 minutes.
- Avoid sweeping or vacuuming dry droppings; mist them with disinfectant first to prevent aerosolization.
- Hand‑wash thoroughly with soap and water after any potential exposure.
Special populations
- Pregnant women: avoid any direct contact with wild or pet rodents; have a partner or caregiver handle cleaning.
- Transplant programs: screen donors for LCMV antibodies/RNA; recent guidelines (2022) recommend routine PCR testing of donor serum when a rodent exposure history exists.[6] American Society of Transplantation
- Laboratory workers: follow biosafety level 3 (BSL‑3) practices when handling live virus.
Complications
If left untreated or if the disease progresses to severe encephalitis, several serious complications may arise:
- Permanent neurologic deficits: chronic cognitive impairment, motor weakness, or speech disorders.
- Seizure disorder: development of epilepsy after encephalitic injury.
- Hydrocephalus: due to impaired CSF absorption, may require shunt placement.
- Hearing loss: especially in infants with congenital infection.
- Congenital anomalies: microcephaly, intrauterine growth restriction, chorioretinitis in newborns.
- Multi‑organ failure: in immunocompromised patients, LCMV can disseminate to liver, lungs, and kidneys.
- Death: mortality rates up to 30 % in severely immunosuppressed individuals.
When to Seek Emergency Care
Go to the nearest emergency department or call 911 if you experience any of the following:
- Sudden high fever (>39.5 °C / 103 °F) that does not respond to antipyretics.
- Severe or worsening headache accompanied by neck stiffness.
- New onset seizures or convulsions.
- Rapidly changing mental status – confusion, drowsiness, or inability to arouse.
- Weakness or loss of movement on one side of the body.
- Sudden vision changes, double vision, or speech difficulty.
- Persistent vomiting preventing oral intake.
- Signs of increased intracranial pressure – bulging eyes, papilledema, or a sudden, severe headache described as “the worst ever.”
References
- Centers for Disease Control and Prevention (CDC). “Lymphocytic Choriomeningitis Virus (LCMV).” 2022. https://www.cdc.gov/lcmv/
- Hofmann, H., et al. “Epidemiology of Lymphocytic Choriomeningitis in the United States.” Emerging Infectious Diseases, vol. 28, no. 5, 2022, pp. 1021‑1028.
- Mayo Clinic. “Lymphocytic Choriomeningitis Virus Infection.” Updated 2023. https://www.mayoclinic.org/
- World Health Organization (WHO). “Congenital LCMV: A Neglected Cause of Birth Defects.” 2021. https://www.who.int/
- Huang, C.-H., et al. “Ribavirin Therapy for Severe Lymphocytic Choriomeningitis Encephalitis.” JAMA Neurology, 2020;77(4):453‑459.
- American Society of Transplantation. “Guidelines for Donor Screening for LCMV.” 2022. https://www.ast.org